medigraphic.com
ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2022, Number 4

<< Back Next >>

Rev Nefrol Dial Traspl 2022; 42 (4)

Morphological patterns of glomerular disease in Mexico: Report of a reference center in nephropathology

Villanueva-Pérez A, Pazarín-Villaseñor L, Soto-Vargas J, Barragán-Medina V, Godínez-Rubí M

Language: Spanish
References: 24
Page: 275-284
PDF size: 274.40 Kb.


ABSTRACT

Introduction: In Mexico, chronic kidney disease (CKD) represents a major health problem, and glomerulopathies (GP) represent the third leading cause of CKD. Aim: From a database of native kidney biopsies (KB), describe the different morphological patterns of GP in Mexico. Methods: Records of native KB in a nephropathology referral center were evaluated by a single nephropathologist. The final diagnosis in each case was based on clinical parameters and histopathological findings. Results: 2084 KB were analyzed, patients were 34.4±17.6 years of age, there were 1085 KB (52.1%) in females; nephrotic syndrome was most frequent in males (p‹0.001), and nephritic syndrome was more frequent in females (p ‹0.001). Primary GP and túbulo-interstitial diseases were most diagnosed in males (p ‹0.01). Lupus nephritis (LN) was the most-reported secondary GP. Focal and segmental glomerulosclerosis (FSGS) was the primary GP most often diagnosed in both genders. The most frequently detected vascular disease was immunoglobulin A vasculitis. Nephrotic syndrome was the most frequent indication for KB (42.9%), followed by: nephritic syndrome (23.9%), isolated proteinuria (16.4%), acute kidney injury (8.7%), asymptomatic urinary alterations (6.2%), and CKD (1.8%). Conclusions: The most frequently observed primary GP was FSGS, and LN was the most frequent secondary GP, predominantly in females, and IgA nephropathy was observed more frequently in comparison with other series published in Mexico. There were significant differences in GP presentation in relation to patient sex and age.


REFERENCES

  1. Characteristics of registered deaths in Mexico.Secretaria de Salud, 2020 at

  2. Méndez-Durán A, Francisco Méndez-Bueno J,Tapia-Yáñez T, Montes AM, Aguilar-Sánchez L:Epidemiology of chronic renal failure in Mexico.Diálisis Traspl 2010; 31:7–11.

  3. O’Shaughnessy MM, Hogan SL, Thompson BD,Coppo R, Fogo AB, Jennette JC: Glomerular diseasefrequencies by race, sex and region: results from theInternational Kidney Biopsy Survey. Nephrol DialTransplant 2018; 33: 661–9.

  4. O’Shaughnessy MM, Montez-Rath ME, LafayetteRA, Winkelmayer WC: Patient Characteristics andOutcomes by GN Subtype in ESRD. Clin J Am SocNephrol 2015; 10:1170–8

  5. Méndez-Durán A, Pérez-Aguilar G, Ayala-Ayala F,Ruiz-Rosas RA, González-Izquierdo J de J, Dávila-Torres J: Epidemiological overview of chronic renalfailure in the second level of care of the Mexican SocialSecurity Institute. Diálisis Traspl 2014; 35:148–56.

  6. Cunningham A, Benediktsson H, Muruve DA,Hildebrand AM, Ravani P: Trends in Biopsy-BasedDiagnosis of Kidney Disease: A Population Study.Can J Kidney Health Dis 2018; 5:205435811879969.

  7. Fiorentino M, Bolignano D, Tesar V, Pisano A, VanBiesen W, D’’Arrigo G, Tripepi G, Gesualdo L,On behalf of the ERA-EDTA ImmunonephrologyWorking Group: Renal Biopsy in 2015 - FromEpidemiology to Evidence-Based Indications. Am JNephrol 2016; 43: 1–19.

  8. Alwahaibi N, Al Issaei H, Al Dhahli B: Spectrum ofglomerular diseases in Arab countries: A systematicreview. Saudi J Kidney Dis Transplant 2018; 29: 1256.

  9. Arias LF, Henao J, Giraldo RD, Carvajal N, RodeloJ, Arbeláez M: Glomerular diseases in a Hispanicpopulation: review of a regional renal biopsy database.Sao Paulo Med J 2009; 127: 140–4.

  10. O’Shaughnessy MM, Hogan SL, Poulton CJ, FalkRJ, Singh HK, Nickeleit V, Jennette JC: Temporaland Demographic Trends in Glomerular DiseaseEpidemiology in the Southeastern United States,1986–2015. Clin J Am Soc Nephrol 2017; 12: 614–23.

  11. Polito MG, Moura LAR de, Kirsztajn GM: Anoverview on frequency of renal biopsy diagnosis inBrazil: clinical and pathological patterns based on9617 native kidney biopsies. Nephrol Dial Transplant2010; 25: 490–6.

  12. Zhou Q, Yang X, Wang M, Wang H, Zhao J, Bi Y,Wang X, Yao J, Chen Y, Lin C, Xie X, Jiang H, ChenJ: Changes in the diagnosis of glomerular diseases ineast China: a 15-year renal biopsy study. Ren Fail2018; 40: 657–64.

  13. Chávez Valencia V, Orizaga de La Cruz C, BecerraFuentes JG, Fuentes Ramírez F, Parra Michel R,Aragaki Y, Márquez Magaña I, Pazarin VillaseñorHL, Villanueva Pérez MA, García Cárdenas MA:[Epidemiology of glomerular disease in adults: adatabase review]. Gac Med Mex 2014; 150: 403–8.

  14. Ríos-Moreno M, Patiño-García G: Characteristics ofidiopathic nephrotic syndrome at an unusual age in atertiary-level pediatric hospital in Guadalajara, Jalisco,México. Bol Med Hosp Infant Mex 2011; 68: 271–7.

  15. Gesualdo L, Di Palma AM, Morrone LF, StrippoliGF, Schena FP: The Italian experience of the nationalregistry of renal biopsies. Kidney Int 2004; 66: 890–4.

  16. Simon P, Ramee M-P, Boulahrouz R, Stanescu C,Charasse C, Seng aNG KIM, Leonetti F, Cam G,Laruelle E, Autuly V, Rioux N: Epidemiologic data ofprimary glomerular diseases in western France. KidneyInt 2004; 66: 905–8.

  17. Muñoz AT, Valdez-Ortiz R, González-Parra C,Espinoza-Dávila E, Morales-Buenrostro LE, Correa-Rotter R: Percutaneous renal biopsy of native kidneys:efficiency, safety and risk factors associated with majorcomplications. Arch Med Sci 2011; 5: 823–31.

  18. Chen L, Luo M, Dong C, Li B, Zhang W, NieP, Liu J, Chen X, Luo P: Pathological spectrum ofglomerular disease in patients with renal insufficiency:a single-center study in Northeastern China. Ren Fail2019; 41: 473–80.

  19. Santos WLC dos-, Sweet GMM, Azevêdo LG,Tavares MB, Soares MFS, Melo CVB de, CarneiroMFM, Santos RF de S, Conrado MC, Braga DTL,Bessa MC, Pinheiro Junior N de F, Bahiense-OliveiraM: Current distribution pattern of biopsy-provenglomerular disease in Salvador, Brazil, 40 years afteran initial assessment. J Bras Nefrol 2017; 39.

  20. Schena FP, Nistor I: Epidemiology of IgANephropathy: A Global Perspective. Semin Nephrol2018; 38: 435–42.

  21. Garau M, Cabrera J, Ottati G, Caorsi H, GonzalezMartinez F, Acosta N, Aunchayna MH, GadolaL, Noboa O: Temporal trends in biopsy provenglomerular disease in Uruguay, 1990-2014. PLOSONE Edited by Remuzzi G. 2018; 13:e0206637.

  22. Kiryluk K, Li Y, Sanna-Cherchi S, RohanizadeganM, Suzuki H, Eitner F, Snyder HJ, Choi M, Hou P,Scolari F, Izzi C, Gigante M, Gesualdo L, Savoldi S,Amoroso A, Cusi D, Zamboli P, Julian BA, NovakJ, Wyatt RJ, Mucha K, Perola M, KristianssonK, Viktorin A, Magnusson PK, Thorleifsson G,Thorsteinsdottir U, Stefansson K, Boland A,Metzger M, et al.: Geographic Differences inGenetic Susceptibility to IgA Nephropathy: GWASReplication Study and Geospatial Risk Analysis. PLoSGenet Edited by McCarthy MI. 2012; 8:e1002765.

  23. Avilés-Santa ML, Monroig-Rivera A, Soto-Soto A,Lindberg NM: Current State of Diabetes MellitusPrevalence, Awareness, Treatment, and Control inLatin America: Challenges and Innovative Solutionsto Improve Health Outcomes Across the Continent.Curr Diab Rep 2020; 20:62.

  24. Rivera F, López-Gómez JM, Pérez-García R:Clinicopathologic correlations of renal pathology inSpain. Kidney Int 2004; 66: 898–904.




2020     |     www.medigraphic.com